- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01871298
Drug User Internet and Mobile Tech Use
November 25, 2015 updated by: Silvia Cunto-Amesty, Columbia University
Exploratory Study of Drug User Health-related Internet and Mobile Technology Use
The purpose of this exploratory study is to examine factors associated with frequency and type of internet and mobile technology use among illegal drug users, specifically use of internet and text-messaging to obtain health care information and engage in health care utilization, specifically human immunodeficiency virus (HIV) prevention and treatment services.
We will target high drug activity neighborhoods in New York City and enroll participants recruited through targeted street outreach.
All participants (n=336) will undergo an audio computer-assisted self-interview (ACASI) that will assess sociodemographics, health care access and utilization, sex/drug use behavior, health status, and characteristics of general and health-related internet/mobile technology use including factors that promote or hinder use.
Participants identified as using the internet ≥1/month (n=151) will return for a 4-week ACASI to report on use of the pilot website (which will largely display information currently available in the community in print/ pamphlet/ video form).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
At the enrollment visit participants deemed eligible after screening will be consented, and given a 30 minute baseline ACASI survey.
At the end of the baseline visit, those participants who reported internet use at least 1x/month (in the past month) will be offered participation in the Pilot Website Evaluation Component.
For this component, participants will be instructed on how to use an educational website with health resources.
Their use of the website will be tracked.
They will be given an appointment to return in 4-weeks for a follow up survey at the pharmacy and a 2-week locator call.
Study Type
Interventional
Enrollment (Actual)
212
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- any lifetime illegal drug use
- age > 18
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Website access
While this pilot intervention is not a randomized trial, study participants who report internet use at least once a month will told of a Pilot Website Evaluation Component that they will be able to access for a 4-week study period.
This website will contain a educational information tailored to the health needs of drug users.
Web content will be similar to materials and public health messages released by the NYC Department of Health and therefore, harm is not likely to arise from viewing such content.
|
The pilot health website will contain educational health information such as: health-related videos, searchable map of HIV prevention and other needed health and social services, and the option to register for automatic text message updates on relevant health information.
|
NO_INTERVENTION: No website access
Participants who report internet use less than once a month will not receive access to the Pilot Website Evaluation Component.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percent of participants who use the pilot website
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percent of participants who use the internet
Time Frame: Baseline
|
Baseline
|
Percent of participants who use the internet at least once a month
Time Frame: Baseline
|
Baseline
|
Percent of participants who use the internet for health-related purposes
Time Frame: Baseline
|
Baseline
|
Percent of participants who are willing to use internet or mobile technology for health-related purposes
Time Frame: Baseline
|
Baseline
|
Percent of participants who sign up for receipt of automatic text message updates on relevant health information
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Silvia Cunto-Amnesty, MD, Assistant Professor of Medicine and Population and Family Health, Dept of Medicine Family Med
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (ACTUAL)
November 1, 2015
Study Completion (ACTUAL)
November 1, 2015
Study Registration Dates
First Submitted
June 4, 2013
First Submitted That Met QC Criteria
June 4, 2013
First Posted (ESTIMATE)
June 6, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
November 26, 2015
Last Update Submitted That Met QC Criteria
November 25, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAL6402
- 1R21DA034841-01A1 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Abuse Illicit
-
NHS Greater Glasgow and ClydePublic Health ScotlandRecruitingDrug Effect | Drug Use | Drug Abuse | Drug Toxicity | Illicit Drug Use | Overdose, Drug | Illicit Drug Overdose | Illicit Drug IntoxicationUnited Kingdom
-
Butler HospitalCompletedIllicit Opioid Drug UseUnited States
-
Vancouver Infectious Diseases CentreGilead Sciences; Regina General HospitalUnknown
-
University Hospital, Clermont-FerrandCSAPA ANPAA 63UnknownOpiate Dependent | Previous Illicit Drug UseFrance
-
Kaiser PermanenteNational Institute on Drug Abuse (NIDA); Stanford UniversityNot yet recruitingAlcohol-Related Disorders | Drug Use Disorders | Illicit Drug Use
-
Kaiser PermanenteNational Institute on Drug Abuse (NIDA)Active, not recruitingAlcohol-Related Disorders | Drug Use Disorders | Illicit Drug UseUnited States
-
Lund UniversityCompletedIntravenous Drug Abuse, S Aureus Colonization
-
Kaohsiung Kai-Suan Psychiatric HospitalChang Gung Memorial Hospital; Kaohsiung Medical UniversityUnknownSubstance Use Disorders | Illicit Drug UseTaiwan
-
Duke UniversityCompletedHealth Behavior | Opioid Use, Unspecified | Benzodiazepine Abuse | Prescription Drug Abuse (Not Dependent) | Benzodiazepine Dependent | Prescription Drug Abuse and DependencyUnited States
-
Boston Medical CenterBoston University; National Institute of Allergy and Infectious Diseases (NIAID) and other collaboratorsEnrolling by invitationTuberculosis | Illicit Drug UseSouth Africa
Clinical Trials on Pilot Website Evaluation Component
-
Hospital Sao DomingosCompleted
-
Nova Scotia Health AuthorityMount Saint Vincent UniversityCompletedTrauma, Psychological | Military Family | Veterans FamilyCanada
-
Regina Elena Cancer InstituteCompleted
-
University of HullBritish Dietetic AssociationCompleted
-
ImmunityBio, Inc.Active, not recruiting